InvestSMART

AdAlta Limited (ASX: 1AD) - Announcements

- Current share price for 1AD : $0.004

ASX company news and announcements for AdAlta Limited (1AD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AdAlta Limited (1AD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AdAlta Limited (1AD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AdAlta Limited (1AD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 CSO presentation at ILD Drug Development Summit 28 Apr 2021 5:24PM $0.150 $0.004 fallen by 97.67%
$11 Quarterly Appendix 4C and Activities Report 20 Apr 2021 8:28AM $0.165 $0.004 fallen by 97.88%
$11 Mutiple Dose Part Of Ad-214 Phase I Trial Commenced 19 Apr 2021 8:25AM $0.165 $0.004 fallen by 97.88%
$11 Appendix 3G 1 Apr 2021 8:31AM $0.165 $0.004 fallen by 97.88%
$11 AdAlta Corporate Overview March 2021 22 Mar 2021 8:26AM $0.178 $0.004 fallen by 98.03%
$11 Investor briefing-AD-214 top line single dose safety results 10 Mar 2021 8:28AM $0.180 $0.004 fallen by 98.06%
$11 AdAlta to host investor briefing 10 March 1 Mar 2021 8:28AM $0.165 $0.004 fallen by 97.88%
$11 Appendix 4D and Interim Financial Report 25 Feb 2021 4:17PM $0.160 $0.004 fallen by 97.81%
$11 FDA Orphan Drug Designation for AD-214 24 Feb 2021 8:16AM $0.175 $0.004 fallen by 98%
$11 Quarterly Appendix 4C and Activities Report 28 Jan 2021 4:32PM $0.135 $0.004 fallen by 97.41%
$11 Phase I HV extension to explore encouraging results 14 Dec 2020 10:12AM $0.125 $0.004 fallen by 97.20%
$11 Change of Director's Interest Notice 30 Nov 2020 8:52AM $0.115 $0.004 fallen by 96.96%
$11 Constitution 26 Nov 2020 11:42AM $0.120 $0.004 fallen by 97.08%
$11 Results of Meeting 25 Nov 2020 2:57PM $0.115 $0.004 fallen by 96.96%
$11 AGM Presentation 25 Nov 2020 10:55AM $0.120 $0.004 fallen by 97.08%
$11 AGM joining and voting instructions 23 Nov 2020 4:48PM $0.115 $0.004 fallen by 96.96%
$11 Notification of Expired Options 9 Nov 2020 8:21AM $0.110 $0.004 fallen by 96.82%
$11 AusBiotech presentation including Phase I status update 27 Oct 2020 8:27AM $0.125 $0.004 fallen by 97.20%
$11 Notice of Annual General Meeting/Proxy Form 22 Oct 2020 8:19AM $0.135 $0.004 fallen by 97.41%
$11 Annual General Meeting - Letter to Shareholders 22 Oct 2020 8:18AM $0.135 $0.004 fallen by 97.41%
$11 R&D Tax Incentive Refund received 19 Oct 2020 9:15AM $0.140 $0.004 fallen by 97.50%
$11 Quarterly Appendix 4C and Activities Report 12 Oct 2020 10:04AM $0.165 $0.004 fallen by 97.88%
$11 Investor Presentation - BIO investor forum 9 Oct 2020 4:07PM $0.155 $0.004 fallen by 97.74%
$11 Response to ASX Price Query 9 Oct 2020 3:56PM $0.155 $0.004 fallen by 97.74%
$11 Change in substantial holding 7 Oct 2020 8:15AM $0.115 $0.004 fallen by 96.96%

451 - 475 of 751 results

Page 19 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.